# EDGAR Filing Document

**Accession Number:** 0001533743
**File Stem:** 0001641172-25-014985
**Filing Date:** 2025-6
**Character Count:** 2163
**Document Hash:** f70a4b35845812a3bd06ea7edc1e7ce7
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001641172-25-014985.hdr.sgml**: 20250717

**ACCESSION NUMBER**: 0001641172-25-014985

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250613

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Processa Pharmaceuticals, Inc.
- **CENTRAL INDEX KEY:** 0001533743
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 451539785
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 7380 COCA COLA DRIVE
- **STREET 2:** SUITE 106
- **CITY:** HANOVER
- **STATE:** MD
- **ZIP:** 21076
- **BUSINESS PHONE:** 443-776-3133

**MAIL ADDRESS:**
- **STREET 1:** 7380 COCA COLA DRIVE
- **STREET 2:** SUITE 106
- **CITY:** HANOVER
- **STATE:** MD
- **ZIP:** 21076

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Heatwurx, Inc.
- **DATE OF NAME CHANGE:** 20111028

**Processa Pharmaceuticals, Inc.**

7380 Coca Cola Drive, Suite 106

Hanover, Maryland 21076

June 13, 2025

**<u>VIA EDGAR</u>**

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, NE

Washington, D.C. 20549

Attention: Mr. Chris Edwards

---

| | |
|:---|:---|
| **Re:** | **Processa Pharmaceuticals, Inc.** |
|  | **Registration Statement on Form S-1 (Registration No. 333-287997)** |

---

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant, Processa Pharmaceuticals, Inc. (the "Registrant"), hereby requests acceleration of effectiveness of its above-referenced Registration Statement to 5:15 P.M., Eastern time, on June 16, 2025, or as soon as practicable thereafter. The Registrant respectfully requests that you notify Mr. Michael Kirwan of Foley & Lardner LLP of such effectiveness by a telephone call to (904) 633-8913.

---

| | |
|:---|:---|
| Very truly yours, | Very truly yours, |
| **Processa Pharmaceuticals, Inc.** | **Processa Pharmaceuticals, Inc.** |
| By: | */s/ George Ng* |
|  | George Ng |
|  | Chief Executive Officer |

---